Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas.

Pishvaian M, Morse MA, McDevitt J, Norton JD, Ren S, Robbie GJ, Ryan PC, Soukharev S, Bao H, Denlinger CS.

Clin Colorectal Cancer. 2016 Dec;15(4):345-351. doi: 10.1016/j.clcc.2016.07.009. Epub 2016 Aug 4.

PMID:
27591895
2.

ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.

Weiler S, Ademokun JA, Norton JD.

Mol Cancer. 2015 Feb 3;14:30. doi: 10.1186/s12943-014-0286-9.

3.

Post-transcriptional regulation of BCL2 mRNA by the RNA-binding protein ZFP36L1 in malignant B cells.

Zekavati A, Nasir A, Alcaraz A, Aldrovandi M, Marsh P, Norton JD, Murphy JJ.

PLoS One. 2014 Jul 11;9(7):e102625. doi: 10.1371/journal.pone.0102625. eCollection 2014.

4.

ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA.

Nasir A, Norton JD, Baou M, Zekavati A, Bijlmakers MJ, Thompson S, Murphy JJ.

PLoS One. 2012;7(12):e52187. doi: 10.1371/journal.pone.0052187. Epub 2012 Dec 20.

5.

Screening for colorectal cancer: established and emerging modalities.

Pawa N, Arulampalam T, Norton JD.

Nat Rev Gastroenterol Hepatol. 2011 Nov 1;8(12):711-22. doi: 10.1038/nrgastro.2011.205. Review.

PMID:
22045159
6.

AU-rich RNA binding proteins in hematopoiesis and leukemogenesis.

Baou M, Norton JD, Murphy JJ.

Blood. 2011 Nov 24;118(22):5732-40. doi: 10.1182/blood-2011-07-347237. Epub 2011 Sep 13.

PMID:
21917750
7.

Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.

Liao CC, Ward N, Marsh S, Arulampalam T, Norton JD.

BMC Cancer. 2010 Aug 6;10:410. doi: 10.1186/1471-2407-10-410.

8.

Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study.

Liao CC, Mehta A, Ward NJ, Marsh S, Arulampalam T, Norton JD.

World J Surg Oncol. 2010 Apr 26;8:33. doi: 10.1186/1477-7819-8-33.

9.

Effects of mode of delivery on mortality and severe brain injury in extremely low birth weight infants in Arkansas.

Barber CA, Sikes NC, Norton JD, Lowery CL, Kaiser JR.

J Ark Med Soc. 2007 Sep;104(3):63-6.

PMID:
17902597
10.

The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression.

Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, Burton GJ, Murphy JJ, Norton JD, Clark AR, Turner M.

Dev Dyn. 2006 Nov;235(11):3144-55.

11.

Equity in the development of telemedicine sites in an Arkansas high-risk pregnancy programme.

Britt DW, Norton JD, Lowery CL.

J Telemed Telecare. 2006;12(5):242-5.

PMID:
16848936
12.
13.

A two-period assessment of changes in specialist contact in a high-risk pregnancy telemedical program.

Britt DW, Norton JD, Hubanks AS, Navidad SA, Perkins RJ, Lowery CL.

Telemed J E Health. 2006 Feb;12(1):35-41.

PMID:
16478411
14.

Findings from selective serotonin reuptake inhibitor-exposed neonates should be interpreted with caution.

Norton JD, Worley LL, Lowery CL.

Pediatrics. 2004 Dec;114(6):1739-40; author reply 1740-1. No abstract available.

PMID:
15574649
15.

A simple wavelet-based test for evoked responses.

Norton JD, Eswaran H, Lowery CL, Wilson JD, Murphy P, Preissl H.

J Neurosci Methods. 2004 Sep 30;138(1-2):157-64.

PMID:
15325124
16.

Id proteins negatively regulate basic helix-loop-helix transcription factor function by disrupting subnuclear compartmentalization.

O'Toole PJ, Inoue T, Emerson L, Morrison IE, Mackie AR, Cherry RJ, Norton JD.

J Biol Chem. 2003 Nov 14;278(46):45770-6. Epub 2003 Sep 1.

17.

Regulation of TCF ETS-domain transcription factors by helix-loop-helix motifs.

Stinson J, Inoue T, Yates P, Clancy A, Norton JD, Sharrocks AD.

Nucleic Acids Res. 2003 Aug 15;31(16):4717-28.

18.

A novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesion.

Murphy JJ, Hobby P, Vilarino-Varela J, Bishop B, Iordanidou P, Sutton BJ, Norton JD.

Biochem J. 2002 Feb 1;361(Pt 3):431-6.

19.

Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.

Wilson JW, Deed RW, Inoue T, Balzi M, Becciolini A, Faraoni P, Potten CS, Norton JD.

Cancer Res. 2001 Dec 15;61(24):8803-10.

20.

Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation.

Kalakonda N, Rothwell DG, Scarffe JH, Norton JD.

Blood. 2001 Sep 1;98(5):1555-60.

PMID:
11520807
21.

Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.

Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD.

Mol Cell Biol. 2001 Jan;21(2):524-33.

22.

ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis.

Norton JD.

J Cell Sci. 2000 Nov;113 ( Pt 22):3897-905. Review.

23.

Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors.

Yates PR, Atherton GT, Deed RW, Norton JD, Sharrocks AD.

EMBO J. 1999 Feb 15;18(4):968-76.

25.

Id helix-loop-helix proteins in cell growth and differentiation.

Norton JD, Deed RW, Craggs G, Sablitzky F.

Trends Cell Biol. 1998 Feb;8(2):58-65. Review.

PMID:
9695810
27.

Coupling of cell growth control and apoptosis functions of Id proteins.

Norton JD, Atherton GT.

Mol Cell Biol. 1998 Apr;18(4):2371-81.

28.

Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis.

Alam MK, Davison S, Siddiqui N, Norton JD, Murphy JJ.

Eur J Immunol. 1997 Dec;27(12):3485-91.

PMID:
9464838
29.

Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation.

Deed RW, Hara E, Atherton GT, Peters G, Norton JD.

Mol Cell Biol. 1997 Dec;17(12):6815-21.

30.

Structure and functional properties of mouse VL30 retrotransposons.

French NS, Norton JD.

Biochim Biophys Acta. 1997 May 2;1352(1):33-47. Review. No abstract available.

PMID:
9177481
31.
32.
33.

Cell cycle arrest defect in Li-Fraumeni Syndrome: a mechanism of cancer predisposition?

Williams KJ, Boyle JM, Birch JM, Norton JD, Scott D.

Oncogene. 1997 Jan 23;14(3):277-82.

35.

Suppression of tumorigenicity in Ras-transformed fibroblasts by alpha 2(I) collagen.

Travers H, French NS, Norton JD.

Cell Growth Differ. 1996 Oct;7(10):1353-60.

36.

Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro.

Ning ZQ, Hirose T, Deed R, Newton J, Murphy JJ, Norton JD.

Biochem J. 1996 Oct 1;319 ( Pt 1):59-65.

37.

Nuclear localization and regulation of Id protein through an E protein-mediated chaperone mechanism.

Deed RW, Armitage S, Norton JD.

J Biol Chem. 1996 Sep 27;271(39):23603-6.

39.

No defect in G1/S cell cycle arrest in irradiated Li-Fraumeni lymphoblastoid cell lines.

Williams KJ, Heighway J, Birch JM, Norton JD, Scott D.

Br J Cancer. 1996 Sep;74(5):698-703.

40.

Regulation of cell differentiation in C2C12 myoblasts by the Id3 helix-loop-helix protein.

Atherton GT, Travers H, Deed R, Norton JD.

Cell Growth Differ. 1996 Aug;7(8):1059-66.

41.

Id2 expression increases with differentiation of human myeloid cells.

Ishiguro A, Spirin KS, Shiohara M, Tobler A, Gombart AF, Israel MA, Norton JD, Koeffler HP.

Blood. 1996 Jun 15;87(12):5225-31.

PMID:
8652837
43.

Early response genes activated by stimulation of human B lymphocytes through different cell surface receptors.

Newton JS, Li J, Ning ZQ, Norton JD, Murphy JJ.

Biochem Soc Trans. 1996 Feb;24(1):7S. No abstract available.

PMID:
8674747
44.

Regulation of Id-HLH transcription factor function in third messenger signalling.

Deed RW, Armitage S, Brown M, Norton JD.

Biochem Soc Trans. 1996 Feb;24(1):5S. No abstract available.

PMID:
8674722
45.

Early response gene expression in Ras oncoprotein signalling.

Travers H, Atherton GT, Deed RW, Norton JD.

Biochem Soc Trans. 1996 Feb;24(1):4S. No abstract available.

PMID:
8674709
46.

Expression of Id2 and Id3 mRNA in human lymphocytes.

Ishiguro A, Spirin K, Shiohara M, Tobler A, Norton JD, Rigolet M, Shimbo T, Koeffler HP.

Leuk Res. 1995 Dec;19(12):989-96.

PMID:
8632670
47.

Onset of action of aqueous beclomethasone dipropionate nasal spray in seasonal allergic rhinitis.

Selner JC, Weber RW, Richmond GW, Stricker WE, Norton JD.

Clin Ther. 1995 Nov-Dec;17(6):1099-109.

PMID:
8750401
48.

Early gene signalling-dependent and -independent induction of apoptosis in Ramos human B cells can be inhibited by over-expression of Bcl-2.

Ning ZQ, Norton JD, Johnson D, Murphy JJ.

Biochem Biophys Res Commun. 1995 Oct 4;215(1):23-9.

PMID:
7575596
49.

Construction of a retroviral vector incorporating mouse VL30 retrotransposon-derived, transcriptional regulatory sequences.

French NS, Norton JD.

Anal Biochem. 1995 Jul 1;228(2):354-5. No abstract available.

PMID:
8572320
50.

Structural organisation and chromosomal mapping of the human Id-3 gene.

Deed RW, Hirose T, Mitchell EL, Santibanez-Koref MF, Norton JD.

Gene. 1994 Dec 30;151(1-2):309-14.

PMID:
7828896

Supplemental Content

Loading ...
Support Center